Trial intelligence / Profile preview

Metformin effect on the ovary in PCOS (MAO study) – pilot study

2006-001911-31Phase 2Completed

Sponsor
Universitätsfrauenklinik Innsbruck
Start
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of metformin in polycystic ovary syndrome (PCOS) and Hyperandrogenemia (HA), sponsored by Universitätsfrauenklinik Innsbruck. Primary endpoint: Normalization of testosterone levels. Started Feb 2007; status: completed.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)Hyperandrogenemia (HA)

Beyond the preview

Go deeper on 2006-001911-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001911-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call